Obesity and diabetes epidemics: Cancer repercussions

Advances in Experimental Medicine and Biology

Volumn 630, Issue , 2008, Pages 72-93

  Hjartåker, Anette ^a   Langseth, Hilde ^a   Weiderpass, Elisabete ^a  

^a Cancer Registry of Norway ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; BIOLOGICAL MODEL; COMORBIDITY; DIABETES MELLITUS; EPIDEMIC; FEMALE; HISTOLOGY; HUMAN; MALE; NEOPLASM; OBESITY; PREVALENCE; REVIEW; RISK FACTOR;

ADIPOSE TISSUE; COMORBIDITY; DIABETES MELLITUS; DISEASE OUTBREAKS; FEMALE; HUMANS; MALE; MODELS, BIOLOGICAL; NEOPLASMS; OBESITY; PREVALENCE; RISK FACTORS;

EID: 49649092692     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-78818-0_6     Document Type: Article

References (107)

1. International Agency for Research on Cancer, World Health Organization. Weight control and physical activity. Vainio H, Bianchini F, editors. 2002. Lyon, IARCPress. IARC Handbooks of Cancer Prevention.
2. Adeghate E, Schattner P, Dunn E. An update on the etiology and epidemiology of diabetes mellitus. Ann NY Acad Sci 2006; 1084:1-29. (Pubitemid 47091962)
3. Trevisan R, Vedovato M, Tiengo A. The epidemiology of diabetes mellitus. Nephrol Dial Transplant 1998; 13 Suppl 8:2-5. (Pubitemid 28532586)
4. World Health Organization. Health topics. 2007; 7-5-2007. Available on: http://www.who.int/topics/obesity/ en.
5. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363(9403):157-163.
6. World Health Organization. 22-4-2007. WHO Global InfoBase Online 2007. Available on: http://www. who.int/infobase/report.aspx.
7. Ogden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295(13):1549-1555.
8. World Health Organization. Diabetes Programme. WHO Country and Regional Data 2007. Available on: http://www.who.int/diabetes/facts/world-figures/en.
9. International Diabetes Federation. Diabetes atlas. International Diabetes Federation-Diabetes Atlas. 2007. Available on: http://www.eatlas.idf.org/.
10. Mlinar B, Marc J, Janez A et al. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta 2007; 375(1-2):20-35. (Pubitemid 44584240)
11. World Health Organization, FAO Expert Consultation. Diet, nutrition and the prevention of chronic diseases. 2003. WHO Technical Report Series.
12. Czyzyk A, Szczepanik Z. Diabetes mellitus and cancer. Eur J Intern Med 2000; 11(5):245-252.
13. Hu FB, Manson JE, Liu S et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999; 91(6):542-547. (Pubitemid 29157063)
14. Shoff SM, Newcomb PA. Diabetes, body size and risk of endometrial cancer. Am J Epidemiol 1998; 148(3):234-240. (Pubitemid 28355341)
15. Silverman DT, Schiffman M, Everhart J et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer 1999; 80(11):1830-1837. (Pubitemid 29389642)
16. Larsson SC, Orsini N, Wolk A. Body mass index and pancreatic cancer risk: A meta-αnalysis of prospective studies. Int J Cancer 2007; 120(9):1993-1998. (Pubitemid 46418379)
17. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4(8):579-591. (Pubitemid 39025053)
18. Bergstrom A, Pisani P, Tenet V et al. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001; 91(3):421-430. (Pubitemid 32049639)
19. Calle EE, Rodriguez C, Walker-Thurmond K et al. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348(17):1625-1638. (Pubitemid 36459468)
20. Strickler HD, Wylie-Rosett J, Rohan T et al. The relation of type 2 diabetes and cancer. Diabetes Technol Ther 2001; 3(2):263-274. (Pubitemid 32651962)
21. International Agency for Research on Cancer. Globocan 2002; Cancer Epidemiology Database. Intenational Agency for Research on Cancer 2002.
22. Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: A systematic review and meta-αnalysis. Cancer Epidemiol Biomarkers Prev 2006; 15(5):872-878. (Pubitemid 43823511)
23. Rubenstein JH, Davis J, Marrero JA et al. Relationship between diabetes mellitus and adenocarcinoma of the oesophagus and gastric cardia. Aliment Pharmacol Ther 2005; 22(3):267-271. (Pubitemid 41153070)
24. Wideroff L, Gridley G, Mellemkjaer L et al. Cancer incidence in a population-βased cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 1997; 89(18):1360-1365. (Pubitemid 27418027)
25. Lindblad M, Rodriguez LA, Lagergren J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia and gastric noncardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control 2005; 16(3):285-294. (Pubitemid 40897847)
26. MacInnis RJ, English DR, Hopper JL et al. Body size and composition and the risk of gastric and oesophageal adenocarcinoma. Int J Cancer 2006; 118(10):2628-2631.
27. Khan M, Mori M, Fujino Y et al. Site-specific cancer risk due to diabetes mellitus history: evidence from the Japan Collaborative Cohort ( JACC) Study. Asian Pac J Cancer Prev 2006; 7(2):253-259.
28. Inoue M, Iwasaki M, Otani T et al. Diabetes mellitus and the risk of cancer: results from a large-scalepopulation-βased cohort study in Japan. Arch Intern Med 2006; 166(17):1871-1877. (Pubitemid 44455170)
29. Zendehdel K, Nyren O, Ostenson CG et al. Cancer incidence in patients with type 1 diabetes mellitus: A population-βased cohort study in Sweden. J Natl Cancer Inst 2003; 95(23):1797-1800. (Pubitemid 38008903)
30. Rennert G. Prevention and early detection of colorectal cancer-new horizons. Recent Results Cancer Res 2007; 174:179-187.
31. Gunter MJ, Leitzmann MF. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem 2006; 17(3):145-156. (Pubitemid 43247408)
32. Sturmer T, Buring JE, Lee IM et al. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study. Cancer Epidemiol Biomarkers Prev 2006; 15(12):2391-2397. (Pubitemid 46048295)
33. Ahmed RL, Schmitz KH, Anderson KE et al. The metabolic syndrome and risk of incident colorectal cancer. Cancer 2006; 107(1):28-36. (Pubitemid 43941640)
34. Bianchini F, Kaaks R, Vainio H. Overweight, obesity and cancer risk. Lancet Oncol 2002; 3(9):565-574.
35. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: A meta-αnalysis. J Natl Cancer Inst 2005; 97(22):1679-1687. (Pubitemid 41672234)
36. Weiderpass E, Gridley G, Persson I et al. Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer 1997; 71(3):360-363. (Pubitemid 27224297)
37. Will JC, Galuska DA, Vinicor F et al. Colorectal cancer: Another complication of diabetes mellitus? Am J Epidemiol 1998; 147(9):816-825. (Pubitemid 28244386)
38. Limburg PJ, Vierkant RA, Fredericksen ZS et al. Clinically confirmed type 2 diabetes mellitus and colorectal cancer risk: A population-βased, retrospective cohort study. Am J Gastroenterol 2006; 101(8):1872-1879. (Pubitemid 44166600)
39. Qian Y, Fan JG. Obesity, fatty liver and liver cancer. Hepatobiliary Pancreat Dis Int 2005; 4(2):173-177.
40. El Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006; 4(3):369-380. (Pubitemid 43343895)
41. Adami HO, Chow WH, Nyren O et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst 1996; 88(20):1472-1477. (Pubitemid 26340049)
42. Davila JA, Morgan RO, Shaib Y et al. Diabetes increases the risk of hepatocellular carcinoma in the United States: A population based case control study. Gut 2005; 54(4):533-539. (Pubitemid 40403031)
43. La Vecchia C, Negri E, Franceschi S et al. A case-control study of diabetes mellitus and cancer risk. Br J Cancer 1994; 70(5):950-953. (Pubitemid 24331093)
44. Lai MS, Hsieh MS, Chiu YH et al. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection. Hepatology 2006; 43(6):1295-1302.
45. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer 2006; 118(7):1591-1602. (Pubitemid 43376420)
46. Larsson SC, Wolk A. Obesity and the risk of gallbladder cancer: A meta-αnalysis. Br J Cancer 2007; 96(9):1457-1461. (Pubitemid 46685777)
47. Swerdlow AJ, Laing SP, Qiao Z et al. Cancer incidence and mortality in patients with insulin-treated diabetes: A UK cohort study. Br J Cancer 2005; 92(11):2070-2075. (Pubitemid 40897432)
48. Michaud DS. Epidemiology of pancreatic cancer. Minerva Chir 2004; 59(2):99-111. (Pubitemid 39062369)
49. Berrington dG, Sweetland S, Spencer E. A meta-αnalysis of obesity and the risk of pancreatic cancer. Br J Cancer 2003; 89(3):519-523. (Pubitemid 37026437)
50. Chari ST, Leibson CL, Rabe KG et al. Probability of pancreatic cancer following diabetes: A population-βased study. Gastroenterology 2005; 129(2):504-511. (Pubitemid 41096638)
51. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A et al. Type-II diabetes and pancreatic cancer: A meta-αnalysis of 36 studies. Br J Cancer 2005; 92(11):2076-2083. (Pubitemid 40897433)
52. Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-αnalysis. JAMA 1995; 273(20):1605-1609.
53. Samanic C, Chow WH, Gridley G et al. Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 2006; 17(7):901-909. (Pubitemid 44078281)
54. Steenland K, Nowlin S, Palu S. Cancer incidence in the National Health and Nutrition Survey I. Follow-up data: diabetes, cholesterol, pulse and physical activity. Cancer Epidemiol Biomarkers Prev 1995; 4(8):807-811.
55. Adami HO, McLaughlin J, Ekbom A et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control 1991; 2(5):307-314.
56. Ragozzino M, Melton LJ III, Chu CP et al. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis 1982; 35(1):13-19. (Pubitemid 12213476)
57. Hall GC, Roberts CM, Boulis M et al. Diabetes and the risk of lung cancer. Diabetes Care 2005; 28(3):590-594. (Pubitemid 40315318)
58. Hanbali A, Al Khasawneh K, Cole-Johnson C et al. Protective effect of diabetes against metastasis in patients with nonsmall cell lung cancer. Arch Intern Med 2007; 167(5):513. (Pubitemid 46425669)
59. Gallus S, Naldi L, Martin L et al. Anthropometric measures and risk of cutaneous malignant melanoma: A case-control study from Italy. Melanoma Res 2006; 16(1):83-87. (Pubitemid 44133056)
60. Chuang TY, Lewis DA, Spandau DF. Decreased incidence of nonmelanoma skin cancer in patients with type 2 diabetes mellitus using insulin: A pilot study. Br J Dermatol 2005; 153(3):552-557. (Pubitemid 41248212)
61. Michels KB, Terry KL, Willett WC. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med 2006; 166(21):2395-2402. (Pubitemid 44833368)
62. Tehard B, Clavel-Chapelon F. Several anthropometric measurements and breast cancer risk: results of the E3N cohort study. Int J Obes (Lond) 2006; 30(1):156-163. (Pubitemid 41790792)
63. Carmichael AR. Obesity and prognosis of breast cancer. Obes Rev 2006; 7(4):333-340. (Pubitemid 44564304)
64. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001; 2(3):133-140. (Pubitemid 33585924)
65. Key TJ, Appleby PN, Reeves GK et al. Body mass index, serum sex hormones and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003; 95(16):1218-1226. (Pubitemid 37069552)
66. Stephenson GD, Rose DP. Breast cancer and obesity: An update. Nutr Cancer 2003; 45(1):1-16. (Pubitemid 36736886)
67. Morimoto LM, White E, Chen Z et al. Obesity, body size and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control 2002; 13(8):741-751. (Pubitemid 35204050)
68. La Vecchia C, Negri E, Franceschi S et al. Body mass index and post-menopausal breast cancer: An age-specific analysis. Br J Cancer 1997; 75(3):441-444. (Pubitemid 27051064)
69. van der BB, Rutteman GR, Blankenstein MA et al. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen. J Cell Physiol 1988; 134(1):101-108. (Pubitemid 18034935)
70. Mathieu MC, Clark GM, Allred DC et al. Insulin receptor expression and clinical outcome in node-negative breast cancer. Proc Assoc Am Physicians 1997; 109(6):565-571. (Pubitemid 27495695)
71. Papa V, Belfiore A. Insulin receptors in breast cancer: biological and clinical role. J Endocrinol Invest 1996; 19(5):324-333. (Pubitemid 126450113)
72. Goodwin PJ, Ennis M, Pritchard KI et al. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 2002; 20(1):42-51. (Pubitemid 34032594)
73. Yang G, Lu G, Jin F et al. Population-βased, case-control study of blood C-peptide level and breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001; 10(11):1207-1211. (Pubitemid 33064310)
74. Nyholm H, Djursing H, Hagen C et al. Androgens and estrogens in postmenopausal insulin-treated diabetic women. J Clin Endocrinol Metab 1989; 69(5):946-949. (Pubitemid 19261822)
75. Lawlor DA, Smith GD, Ebrahim S. Hyperinsulinaemia and increased risk of breast cancer: findings from the British Women's Heart and Health Study. Cancer Causes Control 2004; 15(3):267-275. (Pubitemid 38988035)
76. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: A meta-αnalysis. Int J Cancer 2007; 121(4):856-862. (Pubitemid 47106217)
77. Wolf I, Sadetzki S, Catane R et al. Diabetes mellitus and breast cancer. Lancet Oncol 2005; 6(2):103-111. (Pubitemid 40197704)
78. Wu AH, Yu MC, Tseng CC et al. Diabetes and risk of breast cancer in Asian-American women. Carcinogenesis 2007; 28(7):1561-1566. (Pubitemid 47241806)
79. Modesitt SC, van NJ, Jr. The impact of obesity on the incidence and treatment of gynecologic cancers: A review. Obstet Gynecol Surv 2005; 60(10):683-692. (Pubitemid 41368535)
80. Chang SC, Lacey JV, Jr, Brinton LA et al. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 2007; 16(4):723-730. (Pubitemid 46650574)
81. Chia VM, Newcomb PA, Trentham-Dietz A et al. Obesity, diabetes and other factors in relation to survival after endometrial cancer diagnosis. Int J Gynecol Cancer 2007; 17(2):441-446. (Pubitemid 46426761)
82. Weiderpass E, Persson I, Adami HO et al. Body size in different periods of life, diabetes mellitus, hypertension and risk of postmenopausal endometrial cancer (Sweden). Cancer Causes Control 2000; 11(2):185-192. (Pubitemid 30088399)
83. Iatrakis G, Zervoudis S, Saviolakis A et al. Women younger than 50 years with endometrial cancer. Eur J Gynaecol Oncol 2006; 27(4):399-400. (Pubitemid 44407877)
84. Olsen CM, Green AC, Whiteman DC et al. Obesity and the risk of epithelial ovarian cancer: A systematic review and meta-αnalysis. Eur J Cancer 2007; 43(4):690-709. (Pubitemid 46502901)
85. Mori M, Saitoh S, Takagi S et al. A Review of Cohort Studies on the Association Between History of Diabetes Mellitus and Occurrence of Cancer. Asian Pac J Cancer Prev 2000; 1(4):269-276.
86. Weiderpass E, Ye W, Vainio H et al. Diabetes mellitus and ovarian cancer (Sweden). Cancer Causes Control 2002; 13(8):759-764. (Pubitemid 35204052)
87. Freedland SJ, Giovannucci E, Platz EA. Are findings from studies of obesity and prostate cancer really in conflict? Cancer Causes Control 2006; 17(1):5-9. (Pubitemid 43083664)
88. Littman AJ, White E, Kristal AR. Anthropometrics and Prostate Cancer Risk. Am J Epidemiol 2007; 165(11): 1271-1279.
89. Moyad MA. Is obesity a risk factor for prostate cancer and does it even matter? A hypothesis and different perspective. Urology 2002; 59(4A Suppl):41-50. (Pubitemid 34286430)
90. Bonovas S, Filioussi K, Tsantes A. Diabetes mellitus and risk of prostate cancer: A meta-αnalysis. Diabetologia 2004; 47(6):1071-1078. (Pubitemid 38918167)
91. Kasper JS, Giovannucci E. A meta-αnalysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15(11):2056-2062. (Pubitemid 44877026)
92. Calton BA, Chang SC, Wright ME et al. History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study. Cancer Causes Control 2007; 18(5):493-503. (Pubitemid 46684823)
93. Gonzalez-Perez A, Garcia Rodriguez LA. Prostate cancer risk among men with diabetes mellitus (Spain). Cancer Causes Control 2005; 16(9):1055-1058. (Pubitemid 41356002)
94. Weiderpass E, Ye W, Vainio H et al. Reduced risk of prostate cancer among patients with diabetes mellitus. Int J Cancer 2002; 102(3):258-261. (Pubitemid 35222294)
95. Moore LE, Wilson RT, Campleman SL. Lifestyle factors, exposures, genetic susceptibility and renal cell cancer risk: A review. Cancer Invest 2005; 23(3):240-255 (Pubitemid 40770742)
96. Bjorge T, Tretli S, Engeland A. Relation of height and body mass index to renal cell carcinoma in two million Norwegian men and women. Am J Epidemiol 2004; 160(12):1168-1176. (Pubitemid 39628057)
97. Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol 2006; 176(6 Pt 1):2353-2358. (Pubitemid 44665976)
98. Lindblad P, Chow WH, Chan J et al. The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia 1999; 42(1):107-112. (Pubitemid 29039747)
99. Washio M, Mori M, Khan M et al. Diabetes mellitus and kidney cancer risk: The results of Japan Collaborative Cohort Study for Evaluation of Cancer Risk ( JACC Study). Int J Urol 2007; 14(5):393-397. (Pubitemid 46776217)
100. Holick CN, Giovannucci EL, Stampfer MJ et al. Prospective study of body mass index, height, physical activity and incidence of bladder cancer in US men and women. Int J Cancer 2007; 120(1):140-146. (Pubitemid 44910995)
101. Larsson SC, Orsini N, Brismar K et al. Diabetes mellitus and risk of bladder cancer: A meta-αnalysis. Diabetologia 2006; 49(12):2819-2823. (Pubitemid 44730282)
102. Kravchick S, Gal R, Cytron S et al. Increased incidence of diabetes mellitus in the patients with transitional cell carcinoma of urinary bladder. Pathol Oncol Res 2001; 7(1):56-59. (Pubitemid 32591669)
103. Dal Maso L, La Vecchia C, Franceschi S et al. A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control 2000; 11(2):137-144. (Pubitemid 30088392)
104. Iribarren C, Haselkorn T, Tekawa IS et al. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer 2001; 93(5):745-750. (Pubitemid 32695128)
105. Skibola CF. Obesity, diet and risk of nonHodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007; 16(3):392-395. (Pubitemid 46548638)
106. Larsson SC, Wolk A. Obesity and risk of nonHodgkin's lymphoma: A meta-αnalysis. Int J Cancer 2007; 121(7):1564-1570. (Pubitemid 47328717)
107. US Census Bureau; population census. IDB data access-display mode. Available on: http://www.census. gov/ipc/www/idbprint.html